TGFB1 and pulmonary fibrosis: Indeed, AZM has been reported to suppress EMT mediated by TGF-β1 [89,90,91] and to reduce TGF-β-induced collagen production in fibroblasts from idiopathic pulmonary fibrosis (IPF) patients [92].